This paper describes the use of nanotechnology in detection of disease at its earliest stage. Nanotechnology makes it possible to envision new devices that can deliver a 100-fold and even larger increase in sensitivity over current diagnostic techniques. Very small-scale diagnostic devices have been designed depending on the transduction mechanism—mechanical or electrical—of the biomedical stimulus. Devices that use nanocantilevers, nanowires, and nanoparticles have been built and tested, and are currently under development. The nanowire-based devices are nanometer-wide semiconductor wires coated with molecules arranged in parallel on the bottom of a microfluidic chamber where a blood sample is introduced for analysis. The binding event among the molecules on the wire and the biomarkers in the sample produces a change in the electrical conductivity of the wire that can be measured in real time and related to the amount of biomarkers in solution.
Fantastic Voyages
Paolo Decuzzi is associate professor of mechanical and biomedical engineering at the Center of Bio-Nanotechnology and Bio-Engineering for Medicine in the School of Medicine of the University of Magna Graecia in Catanzaro. Italy. and at the Center of Excellence in Computational Mechanics in the School of Engineering of the Politecnico di Bari. Mauro Ferrari is professor in the Brown Institute of Molecular Medicine at the University of Texas Health Science Center in Houston. professor of experimental therapeutics at M.D. Anderson Cancer Center. and professor of biomedical engineering at Rice University.
Decuzzi, P., and Ferrari, M. (October 1, 2006). "Fantastic Voyages." ASME. Mechanical Engineering. October 2006; 128(10): 24–27. https://doi.org/10.1115/1.2006-OCT-1
Download citation file: